Glimepiride

Routes
Oral (PO)
Half-Life (t½)
PO: 8.2h
Formula
C24H34N4O5S
Molecular Weight
490.62 g/mol
PubChem CID
3476
Aliases
Amaryl

Pharmacological Mechanism

Third-generation sulfonylurea — same K-ATP β-cell mechanism but lower hypoglycemia rate than glyburide. CYP2C9 substrate. Once-daily dosing.

Half-Life & Elimination Curve (PO: 8.2h)

100%50%25%12.5%0%0h0×t½8.2h1×t½16.4h2×t½24.6h3×t½32.8h4×t½41h5×t½0×t½ (0h): 100% remaining (~0.383 mg/L)1×t½ (8.2h): 50% remaining (~0.191 mg/L)2×t½ (16.4h): 25% remaining (~95.7 µg/L)3×t½ (24.6h): 12.5% remaining (~47.9 µg/L)4×t½ (32.8h): 6.3% remaining (~23.9 µg/L)5×t½ (41h): 3.1% remaining (~12 µg/L)
Plasma (PO)t½ Decay (8.2h)
  • 0×t½0h100% (0.383 mg/L)
  • 1×t½8.2h50% (0.191 mg/L)
  • 2×t½16.4h25% (95.7 µg/L)
  • 3×t½24.6h12.5% (47.9 µg/L)
  • 4×t½32.8h6.3% (23.9 µg/L)
  • 5×t½41h3.1% (12 µg/L)
Elimination t½8.2h (PO)
Rate Constant (ke)0.0845 h⁻¹
Time to Peak (Tmax)2.03h
Est. Peak (Cmax)0.383 mg/L
Clearance (CL)0.744 L/h
97% Washout (5×t½)41h

Dosing Guidelines

Pharmacokinetic Parameters

Pathways It Modulates

Target Organ Systems

Chemical Structure & Identifiers

References